Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT04573751

The EPIVER Randomized Controlled Trial

Conditions: ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, No-Reflow Phenomenon

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 104

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences

Location: Cardiology Research Institute, Tomsk NRMC Tomsk Tomsk Oblast

Summary

The trial aims to estimate the efficacy and safety of the intracoronary administration of adrenalin, verapamil, as well as their combination compared to standard treatment in patients with STEMI and refractory coronary no-reflow despite conventional treatment during percutaneous coronary intervention (PPCI)

Eligibility Criteria

Inclusion Criteria: * patients with ST-elevation myocardial infarction * Infarct-related artery TIMI flow grade 0-2 during the interventional procedure after the initial opening of the vessel. * Written the informed consent to participate in research Exclusion Criteria: * Unable to undergo or contra-indications for MRI or SPECT

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04573751). StuddyBuddy aggregates publicly available trial information.